Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report
Gespeichert in:
| Veröffentlicht in: | Inflammatory bowel diseases 2020-12, Vol.26 (12), p.e155-e156 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e156 |
|---|---|
| container_issue | 12 |
| container_start_page | e155 |
| container_title | Inflammatory bowel diseases |
| container_volume | 26 |
| creator | Queiroz, Natália Sousa Freitas Graciolli, Carolina Bortolozzo Sobrado, Carlos Walter |
| description | |
| doi_str_mv | 10.1093/ibd/izaa194 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A697884110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A697884110</galeid><oup_id>10.1093/ibd/izaa194</oup_id><sourcerecordid>A697884110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-b41f28b6fccfe7657bbe3478e77922a42f36efe1a064da3d182769ab194d8d7a3</originalsourceid><addsrcrecordid>eNp9kM1LxDAQxYMofp-8S0DwItWkzSapt2VZP2BREb0JZZpOJNI2JemC-tcbWRUEkTnMMPN7D-YRcsDZKWdlcebq5sy9A_BSrJFtPilkJrQQ62lmSmesLPUW2YnxhbE8VblJtopcKiml3iZP89fBx2VAOnr64C0YN7re1fTGj_QeWxix-Tzdo1mGgL1B6i2d9tDSu4AdtO65h36kC4zO9-d0SmcQMeGDD-Me2bDQRtz_6rvk8WL-MLvKFreX17PpIjPFRIxZLbjNdS2tMRaVnKi6xkIojUqVeQ4it4VEixyYFA0UDde5kiXU6eFGNwqKXXK08n2GFivXWz8GMJ2LpprKUmktOGeJOv2DStVg54zv0bq0_yU4WQlM8DEGtNUQXAfhreKs-oy-StFXX9En-nBFD8u6w-aH_c46AccrwC-Hf50-AB9KjBI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Queiroz, Natália Sousa Freitas ; Graciolli, Carolina Bortolozzo ; Sobrado, Carlos Walter</creator><creatorcontrib>Queiroz, Natália Sousa Freitas ; Graciolli, Carolina Bortolozzo ; Sobrado, Carlos Walter</creatorcontrib><identifier>ISSN: 1078-0998</identifier><identifier>EISSN: 1536-4844</identifier><identifier>DOI: 10.1093/ibd/izaa194</identifier><identifier>PMID: 32676668</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Immunosuppressive agents ; Ulcerative colitis</subject><ispartof>Inflammatory bowel diseases, 2020-12, Vol.26 (12), p.e155-e156</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020</rights><rights>COPYRIGHT 2020 Oxford University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-b41f28b6fccfe7657bbe3478e77922a42f36efe1a064da3d182769ab194d8d7a3</citedby><cites>FETCH-LOGICAL-c354t-b41f28b6fccfe7657bbe3478e77922a42f36efe1a064da3d182769ab194d8d7a3</cites><orcidid>0000-0003-2857-0825</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32676668$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Queiroz, Natália Sousa Freitas</creatorcontrib><creatorcontrib>Graciolli, Carolina Bortolozzo</creatorcontrib><creatorcontrib>Sobrado, Carlos Walter</creatorcontrib><title>Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report</title><title>Inflammatory bowel diseases</title><addtitle>Inflamm Bowel Dis</addtitle><subject>Immunosuppressive agents</subject><subject>Ulcerative colitis</subject><issn>1078-0998</issn><issn>1536-4844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kM1LxDAQxYMofp-8S0DwItWkzSapt2VZP2BREb0JZZpOJNI2JemC-tcbWRUEkTnMMPN7D-YRcsDZKWdlcebq5sy9A_BSrJFtPilkJrQQ62lmSmesLPUW2YnxhbE8VblJtopcKiml3iZP89fBx2VAOnr64C0YN7re1fTGj_QeWxix-Tzdo1mGgL1B6i2d9tDSu4AdtO65h36kC4zO9-d0SmcQMeGDD-Me2bDQRtz_6rvk8WL-MLvKFreX17PpIjPFRIxZLbjNdS2tMRaVnKi6xkIojUqVeQ4it4VEixyYFA0UDde5kiXU6eFGNwqKXXK08n2GFivXWz8GMJ2LpprKUmktOGeJOv2DStVg54zv0bq0_yU4WQlM8DEGtNUQXAfhreKs-oy-StFXX9En-nBFD8u6w-aH_c46AccrwC-Hf50-AB9KjBI</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Queiroz, Natália Sousa Freitas</creator><creator>Graciolli, Carolina Bortolozzo</creator><creator>Sobrado, Carlos Walter</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-2857-0825</orcidid></search><sort><creationdate>20201201</creationdate><title>Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report</title><author>Queiroz, Natália Sousa Freitas ; Graciolli, Carolina Bortolozzo ; Sobrado, Carlos Walter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-b41f28b6fccfe7657bbe3478e77922a42f36efe1a064da3d182769ab194d8d7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Immunosuppressive agents</topic><topic>Ulcerative colitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Queiroz, Natália Sousa Freitas</creatorcontrib><creatorcontrib>Graciolli, Carolina Bortolozzo</creatorcontrib><creatorcontrib>Sobrado, Carlos Walter</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Inflammatory bowel diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Queiroz, Natália Sousa Freitas</au><au>Graciolli, Carolina Bortolozzo</au><au>Sobrado, Carlos Walter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report</atitle><jtitle>Inflammatory bowel diseases</jtitle><addtitle>Inflamm Bowel Dis</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>26</volume><issue>12</issue><spage>e155</spage><epage>e156</epage><pages>e155-e156</pages><issn>1078-0998</issn><eissn>1536-4844</eissn><cop>US</cop><pub>Oxford University Press</pub><pmid>32676668</pmid><doi>10.1093/ibd/izaa194</doi><orcidid>https://orcid.org/0000-0003-2857-0825</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1078-0998 |
| ispartof | Inflammatory bowel diseases, 2020-12, Vol.26 (12), p.e155-e156 |
| issn | 1078-0998 1536-4844 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A697884110 |
| source | Oxford University Press Journals All Titles (1996-Current) |
| subjects | Immunosuppressive agents Ulcerative colitis |
| title | Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A23%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exposure%20to%20Tofacitinib%20Not%20Related%20to%20Recurrence%20of%20Anal%20Premalignant%20Lesion:%20A%20Case%20Report&rft.jtitle=Inflammatory%20bowel%20diseases&rft.au=Queiroz,%20Nat%C3%A1lia%20Sousa%20Freitas&rft.date=2020-12-01&rft.volume=26&rft.issue=12&rft.spage=e155&rft.epage=e156&rft.pages=e155-e156&rft.issn=1078-0998&rft.eissn=1536-4844&rft_id=info:doi/10.1093/ibd/izaa194&rft_dat=%3Cgale_cross%3EA697884110%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32676668&rft_galeid=A697884110&rft_oup_id=10.1093/ibd/izaa194&rfr_iscdi=true |